All-cause mortality and risk factors in patients with type 1 diabetes in Castilla-La Mancha, Spain. DIACAM1 2010–2020 study

IF 2.6 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM Primary Care Diabetes Pub Date : 2024-02-01 DOI:10.1016/j.pcd.2023.11.003
Pedro José Pinés Corrales , Julia Sastre Marcos , Gema López Gallardo , Jesús Moreno Fernández , Sandra Herranz Antolín , Iván Quiroga López , Florentino Del Val Zaballos , Javier González López , José Joaquín Alfaro Martínez , In representation of the DIACAM1 2010–2020 group
{"title":"All-cause mortality and risk factors in patients with type 1 diabetes in Castilla-La Mancha, Spain. DIACAM1 2010–2020 study","authors":"Pedro José Pinés Corrales ,&nbsp;Julia Sastre Marcos ,&nbsp;Gema López Gallardo ,&nbsp;Jesús Moreno Fernández ,&nbsp;Sandra Herranz Antolín ,&nbsp;Iván Quiroga López ,&nbsp;Florentino Del Val Zaballos ,&nbsp;Javier González López ,&nbsp;José Joaquín Alfaro Martínez ,&nbsp;In representation of the DIACAM1 2010–2020 group","doi":"10.1016/j.pcd.2023.11.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Despite better treatments and care for patients with type 1 diabetes (T1DM), all-cause and cardiovascular mortality still remains higher compared to the general population. We evaluated mortality and risk factors for mortality in a representative cohort of patients with T1DM.</p></div><div><h3>Methods</h3><p>DIACAM1 was a cross-sectional, multicenter study on adult patients (≥ 16 years old) and diabetes with at least 5 years since diabetes diagnosis conducted between 2009 and 2010. DIACAM1 2010–2020 study was a follow-up study, extension of DIACAM1, where vital status of patients was evaluated between June 2019 and June 2020.</p></div><div><h3>Results</h3><p>4.03% [CI95%, 2.53–5.62) of the 1465 patients with T1DM included in the cohort of the DIACAM1 in 2010 had died. <strong>Survival was lower than in the sex- and age-matched general population in the same region</strong>. 40.7% of deaths were due to cardiovascular disease. HbA1c levels &lt; 7% and triglyceride levels &lt; 150 mg/dL were associated with lower mortality, whereas retinopathy and plasma creatinine were associated with increased mortality.</p></div><div><h3>Conclusions</h3><p>We confirmed a lower survival in people with T1DM, with cardiovascular disease being the main cause of mortality. High HbA1c, high triglycerides, retinopathy, and high creatinine are factors associated with mortality.</p></div>","PeriodicalId":48997,"journal":{"name":"Primary Care Diabetes","volume":"18 1","pages":"Pages 59-64"},"PeriodicalIF":2.6000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Primary Care Diabetes","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1751991823001833","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Despite better treatments and care for patients with type 1 diabetes (T1DM), all-cause and cardiovascular mortality still remains higher compared to the general population. We evaluated mortality and risk factors for mortality in a representative cohort of patients with T1DM.

Methods

DIACAM1 was a cross-sectional, multicenter study on adult patients (≥ 16 years old) and diabetes with at least 5 years since diabetes diagnosis conducted between 2009 and 2010. DIACAM1 2010–2020 study was a follow-up study, extension of DIACAM1, where vital status of patients was evaluated between June 2019 and June 2020.

Results

4.03% [CI95%, 2.53–5.62) of the 1465 patients with T1DM included in the cohort of the DIACAM1 in 2010 had died. Survival was lower than in the sex- and age-matched general population in the same region. 40.7% of deaths were due to cardiovascular disease. HbA1c levels < 7% and triglyceride levels < 150 mg/dL were associated with lower mortality, whereas retinopathy and plasma creatinine were associated with increased mortality.

Conclusions

We confirmed a lower survival in people with T1DM, with cardiovascular disease being the main cause of mortality. High HbA1c, high triglycerides, retinopathy, and high creatinine are factors associated with mortality.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
西班牙Castilla-La Mancha地区1型糖尿病患者的全因死亡率和危险因素DIACAM1 2010-2020研究。
导论:尽管对1型糖尿病(T1DM)患者的治疗和护理有所改善,但与一般人群相比,全因和心血管死亡率仍然较高。我们评估了一组典型T1DM患者的死亡率和死亡率的危险因素。方法:DIACAM1是一项横断面、多中心研究,研究对象为2009年至2010年诊断为糖尿病至少5年的成年患者(≥16岁)和糖尿病。DIACAM1 2010-2020研究是一项随访研究,是DIACAM1的延伸,在2019年6月至2020年6月期间评估患者的重要状态。结果:2010年纳入DIACAM1队列的1465例T1DM患者中有4.03% (CI95%, 2.53-5.62)死亡。生存率低于同一地区性别和年龄相匹配的一般人群。40.7%的死亡是由于心血管疾病。结论:我们证实T1DM患者的生存率较低,心血管疾病是死亡的主要原因。高HbA1c、高甘油三酯、视网膜病变和高肌酐是与死亡率相关的因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Primary Care Diabetes
Primary Care Diabetes ENDOCRINOLOGY & METABOLISM-PRIMARY HEALTH CARE
CiteScore
5.00
自引率
3.40%
发文量
134
审稿时长
47 days
期刊介绍: The journal publishes original research articles and high quality reviews in the fields of clinical care, diabetes education, nutrition, health services, psychosocial research and epidemiology and other areas as far as is relevant for diabetology in a primary-care setting. The purpose of the journal is to encourage interdisciplinary research and discussion between all those who are involved in primary diabetes care on an international level. The Journal also publishes news and articles concerning the policies and activities of Primary Care Diabetes Europe and reflects the society''s aim of improving the care for people with diabetes mellitus within the primary-care setting.
期刊最新文献
Contents Editorial Board and Aims & Scopes Proactive total diet replacement referral for type 2 diabetes: A service evaluation Impact of lifestyle intervention on vitamin D, Adiponectin, Insulin-like growth factor 1 and Proneurotensin in overweight individuals from the Middle East Re-purposing SGLT-2 inhibitors for diabetic striatopathy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1